Horizon Technology Finance
$ 6.34
1.12%
30 Dec - close price
- Market Cap 281,390,000 USD
- Current Price $ 6.34
- High / Low $ 6.38 / 6.25
- Stock P/E N/A
- Book Value 7.12
- EPS -0.63
- Next Earning Report 2026-02-25
- Dividend Per Share $1.32
- Dividend Yield 21 %
- Next Dividend Date 2026-03-13
- ROA 0.07 %
- ROE -0.07 %
- 52 Week High 8.57
- 52 Week Low 5.52
About
None
Analyst Target Price
$6.80
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-29 | 2025-07-28 | 2025-04-28 | 2025-02-25 | 2024-10-29 | 2024-07-30 | 2024-04-30 | 2024-02-27 | 2023-10-31 | 2023-08-01 | 2023-05-02 | 2023-02-28 |
| Reported EPS | 0.3111 | 0.28 | 0.27 | 0.27 | 0.32 | 0.36 | 0.38 | 0.45 | 0.53 | 0.54 | 0.46 | 0.4 |
| Estimated EPS | 0.274 | 0.2838 | 0.3258 | 0.3183 | 0.35 | 0.36 | 0.38 | 0.44 | 0.41 | 0.41 | 0.4 | 0.39 |
| Surprise | 0.0371 | -0.0038 | -0.0558 | -0.0483 | -0.03 | 0 | 0 | 0.01 | 0.12 | 0.13 | 0.06 | 0.01 |
| Surprise Percentage | 13.5401% | -1.339% | -17.1271% | -15.1744% | -8.5714% | 0% | 0% | 2.2727% | 29.2683% | 31.7073% | 15% | 2.5641% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-25 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.2932 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Feb 2026 | Jan 2026 | Dec 2025 | Nov 2025 | Oct 2025 | Sep 2025 | Aug 2025 | Jul 2025 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-13 | 2026-02-13 | 2026-01-15 | 2025-12-16 | 2025-11-14 | 2025-10-15 | 2025-09-16 | 2025-08-15 | 2025-07-15 | 2025-06-13 |
| Amount | $0.11 | $0.11 | $0.11 | $0.11 | $0.11 | $0.11 | $0.11 | $0.11 | $0.11 | $0.11 |
Next Dividend Records
| Dividend per share (year): | $1.32 |
| Dividend Yield | 21% |
| Next Dividend Date | 2026-03-13 |
| Ex-Dividend Date | 2026-01-16 |
Recent News: HRZN
2025-12-23 09:09:13
Horizon Technology Finance Corporation (NASDAQ:HRZN) has received an average analyst recommendation of "Reduce," with a consensus price target of $7.00. Despite beating quarterly earnings estimates, the company remains unprofitable and has a negative payout ratio for its high-yield monthly dividend, raising concerns about its sustainability. Institutional investors have recently adjusted their holdings in the specialty finance company.
2025-12-12 13:09:24
Horizon Technology Finance Corporation (Nasdaq: HRZN) announced the pricing of a registered direct offering for $57.50 million aggregate principal amount of 7.00% Notes due 2028. These notes mature on December 15, 2028, and interest will accrue starting December 15, 2025. The company plans to use the net proceeds to repay existing indebtedness, including its 4.875% Notes due 2026, and for general corporate purposes.
2025-10-12 05:33:11
Horizon Technology Finance Corporation (NASDAQ:HRZN) has received a consensus price target of $7.30 from brokerages, with several analysts recently commenting on the stock. The company also declared a monthly dividend of $0.11, implying a 22.4% yield. Additionally, several hedge funds have adjusted their holdings in HRZN, indicating significant institutional interest.
2024-09-12 08:00:00
GT Medical Technologies, Inc. has secured a $35 million venture loan facility from Horizon Technology Finance, with $15 million initially funded. This financing will support the company's strategic commercial and clinical expansion plans for GammaTile®, their innovative targeted radiation solution for brain tumors. The partnership aims to enhance access to care for patients with high-grade gliomas, brain metastases, and aggressive meningiomas, and further expand GammaTile utilization.
2024-04-10 16:15:00
Horizon Technology Finance (NASDAQ: HRZN) announced its first-quarter 2024 portfolio update, highlighting $33.5 million in new loan originations and a committed backlog of $168 million. The company reported $20 million in loan payoffs and partial paydowns, generating accelerated income. Horizon aims to prudently grow its debt investment portfolio and deliver shareholder value.
2024-03-01 07:18:00
Horizon Technology Finance (HRZN) surpassed its net investment income (NII) goals in Q4 2023, reporting $1.98 per share, while maintaining regular and special distributions. Despite this, the company experienced a decline in net asset value (NAV) due to underperforming investments and a challenging venture capital market. Horizon remains optimistic, citing a strong portfolio yield, substantial backlog, and strategic initiatives, expecting a gradual improvement in the venture capital environment in 2024.
